Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02946203 · ClinicalTrials.gov registry record · Phase 4
Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients
A Phase 4 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 66
- Enrollment target
NCT02946203 is a Phase 4 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 66 participants.
The verdict
NCT02946203, a Phase 4 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 66 participants
- Enrollment target
Study Summary
In this research study, two different oral contrast materials that can be used for CT or MR enterography will be studied. This study is designed to compare which oral contrast material (VoLumen or Breeza) is preferred by pediatric patients and which provides higher quality exams.
Interventions
- OTHER Barium Sulfate
- OTHER Flavored beverage Oral Contrast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02946203
The ClinicalTrials.gov registry entry for NCT02946203 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Barium Sulfate is the first listed.
NCT02946203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02946203 about?
NCT02946203 is a clinical study titled "Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients". In this research study, two different oral contrast materials that can be used for CT or MR enterography will be studied. This study is designed to compare which oral contrast material (VoLumen or Breeza) is preferred by pediatric patients and which provides higher quality exams.
What is the current status of trial NCT02946203?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2016-11. Estimated completion is 2017-11.
What interventions are being tested in trial NCT02946203?
The interventions under investigation include: Barium Sulfate (OTHER), Flavored beverage Oral Contrast (OTHER).
Who is sponsoring clinical trial NCT02946203?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.